Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors.
SGLT-2 抑制劑的罕見但嚴重副作用:正常血糖的糖尿病性酮酸中毒。
World J Cardiol 2022-11-08
Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
Empagliflozin 相關的非高血糖性糖尿病性酮酸中毒在一名2型糖尿病患者中。
Cureus 2023-02-24
Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report.
SGLT2 抑制劑治療相關的正常血糖糖尿病性酮酸中毒:一個病例報告。
AACN Adv Crit Care 2023-03-08
Severe euglycemic diabetic ketoacidosis secondary to sodium-glucose co-transporter 2 inhibitor: case report and literature review.
嚴重的正糖尿病酮酸中毒次級於鈉葡萄糖共同運輸蛋白2抑制劑:病例報告與文獻回顧。
Ann Med Surg (Lond) 2023-05-30
Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient.
老年患者因 empagliflozin 引起的正血糖糖尿病性酮酸中毒並併發營養不良。
Arch Clin Cases 2023-06-15
Unsuspected diabetic ketoacidosis after myocardial infarction in a patient treated with SGLT2 inhibitor increased length of stay in the hospital: how can it be prevented? A case report.
SGLT2 抑制劑治療的病人在心肌梗塞後出現不明顯的糖尿病酮酸中毒:如何預防?一個病例報告。
Eur Heart J Case Rep 2023-09-09
The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by the Introduction of Empagliflozin with Simultaneous Reduction of Insulin Dosage.
精確診斷糖尿病的重要性:一例因引入 Empagliflozin 同時減少胰島素劑量而誘發的正常血糖酮酸中毒症。
Eur J Case Rep Intern Med 2024-06-07